Loading…

The Preventive Misconception: Experiences from CAPRISA 004

Overestimating personal protection afforded by participation in a preventive trial, e.g. harboring a “preventive misconception” (PM), raises theoretical ethical concerns about the adequacy of the informed consent process, behavioral disinhibition, and adherence to prevention interventions. Data from...

Full description

Saved in:
Bibliographic Details
Published in:AIDS and behavior 2014-09, Vol.18 (9), p.1746-1752
Main Authors: Dellar, Rachael C., Abdool Karim, Quarraisha, Mansoor, Leila E., Grobler, Anneke, Humphries, Hilton, Werner, Lise, Ntombela, Fanelesibonge, Luthuli, Londiwe, Abdool Karim, Salim S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Overestimating personal protection afforded by participation in a preventive trial, e.g. harboring a “preventive misconception” (PM), raises theoretical ethical concerns about the adequacy of the informed consent process, behavioral disinhibition, and adherence to prevention interventions. Data from the CAPRISA 004 1 % tenofovir gel trial were utilized to empirically evaluate these concerns. We found it necessary to re-think the current definition of PM during evaluation to distinguish between true misconception and reasonable inferences of protection based on increased access to evidence-based prevention interventions and/or clinical care. There was a significant association between PM and decreased condom use ( p  
ISSN:1090-7165
1573-3254
DOI:10.1007/s10461-014-0771-6